Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|
| Total revenue | 13.93%3.97B | 967.48M | 17.33%3.48B | 936.4M | 27.36%2.97B | 2.33B |
| Cost of revenue | 12.91%2.52B | 578.97M | 21.36%2.23B | 580.3M | 29.39%1.84B | 1.42B |
| Gross profit | 15.74%1.45B | 388.51M | 10.78%1.25B | 356.1M | 24.19%1.13B | 910.44M |
| Operating expense | 21.96%1.27B | 317.01M | 8.09%1.04B | 280.83M | 17.65%966.02M | 821.08M |
| Operating profit | -15.42%176.28M | 71.5M | 26.55%208.41M | 75.27M | 84.29%164.69M | 89.36M |
| Net non-operating interest income (expenses) | -9.13%-3.67M | -885K | 44.47%-3.36M | -925K | 51.04%-6.05M | -12.37M |
| Non-operating interest income | 2,560.00%532K | --2K | -25.93%20K | --6K | -15.63%27K | --32K |
| Non-operating interest expense | 24.22%4.2M | --887K | -44.38%3.38M | --931K | -50.95%6.08M | --12.4M |
| Net investment income | ||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -1.46M | |||||
| Income from associates and other participating interests | ||||||
| Special income (charges) | -689.46%-4.14M | 25.58%702K | 108.33%559K | -6.71M | ||
| Less:Other special charges | 414.25%2.21M | ---- | -25.58%-702K | ---- | -108.33%-559K | --6.71M |
| Less:Write off | --1.93M | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 214.53%12.54M | 1.06M | -614.95%-10.95M | -11.56M | -62.70%2.13M | 5.7M |
| Income before tax | -7.82%179.56M | 71.68M | 20.75%194.8M | 63.49M | 112.30%161.32M | 75.99M |
| Income tax | -28.25%35.41M | 14.92M | 285.97%49.35M | 16.58M | -274.73%-26.54M | 15.19M |
| Net income | -0.89%144.15M | 56.76M | -22.57%145.45M | 46.91M | 208.97%187.86M | 60.8M |
| Net income continuous operations | -0.89%144.15M | --56.76M | -22.57%145.45M | --46.91M | 208.97%187.86M | --60.8M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | -0.89%144.15M | 56.76M | -22.58%145.45M | 46.91M | 208.97%187.86M | 60.8M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -0.89%144.15M | 56.76M | -22.58%145.45M | 46.91M | 208.97%187.86M | 60.8M |
| Gross dividend payment | ||||||
| Basic earnings per share | -17.95%25.67 | 10.15 | -24.15%31.2871 | 13.3144 | 271.95%41.2482 | 11.0898 |
| Diluted earnings per share | -19.39%25.22 | 9.96 | -24.15%31.2871 | 8.5565 | 271.95%41.2482 | 11.0898 |
| Dividend per share | ||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |